139 related articles for article (PubMed ID: 34825277)
1. The characteristics of patients with macrovascular invasion in hepatocellular carcinoma: when East meets West.
Yen YH; Li WF; Kee KM; Wang CC; Cheng YF; Wang JH; Lu SN; Hung CH
Langenbecks Arch Surg; 2022 Feb; 407(1):225-234. PubMed ID: 34825277
[TBL] [Abstract][Full Text] [Related]
2. Pattern of macrovascular invasion in hepatocellular carcinoma.
Guarino M; Cucchetti A; Pontillo G; Farinati F; Benevento F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Rodolfo S; Cabibbo G; Marra F; Mega A; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Missale G; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Giannini EG; Morisco F;
Eur J Clin Invest; 2021 Jul; 51(7):e13542. PubMed ID: 33755196
[TBL] [Abstract][Full Text] [Related]
3. Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma.
Lin CW; Chen YS; Lo GH; Wu TC; Yeh JH; Yeh ML; Dai CY; Huang JF; Chuang WL; Roberts L; Jun DW; Toyoda H; Yasuda S; Nguyen MH; Yu ML
Hepatol Int; 2021 Aug; 15(4):946-956. PubMed ID: 34008091
[TBL] [Abstract][Full Text] [Related]
4. Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.
Yen YH; Cheng YF; Wang JH; Lin CC; Chen YY; Yong CC; Liu YW; Cheng JY; Chen CH; Hu TH
PLoS One; 2020; 15(3):e0230005. PubMed ID: 32163475
[TBL] [Abstract][Full Text] [Related]
5. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
[TBL] [Abstract][Full Text] [Related]
6. Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study.
Lee DW; Yim HJ; Seo YS; Na SK; Kim SY; Suh SJ; Hyun JJ; Jung SW; Jung YK; Koo JS; Kim JH; Yeon JE; Lee SW; Byun KS; Um SH
Liver Int; 2019 Jun; 39(6):1109-1119. PubMed ID: 30972935
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
[TBL] [Abstract][Full Text] [Related]
8. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Giannini EG; Bucci L; Garuti F; Brunacci M; Lenzi B; Valente M; Caturelli E; Cabibbo G; Piscaglia F; Virdone R; Felder M; Ciccarese F; Foschi FG; Sacco R; Svegliati Baroni G; Farinati F; Rapaccini GL; Olivani A; Gasbarrini A; Di Marco M; Morisco F; Zoli M; Masotto A; Borzio F; Benvegnù L; Marra F; Colecchia A; Nardone G; Bernardi M; Trevisani F;
Hepatology; 2018 May; 67(5):1784-1796. PubMed ID: 29159910
[TBL] [Abstract][Full Text] [Related]
9. Overall survival and toxicity of Y90 radioembolization for hepatocellular carcinoma patients in Barcelona Clinic Liver Cancer stage C (BCLC-C).
Goswami P; Adeniran OR; K Frantz S; Matsuoka L; Du L; Gandhi RT; Collins ZS; Matrana MR; Petroziello M; Brower JS; Sze DY; Kennedy AS; Golzarian J; Wang EA; Brown DB
BMC Gastroenterol; 2022 Nov; 22(1):467. PubMed ID: 36396989
[TBL] [Abstract][Full Text] [Related]
10. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
11. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns for hepatocellular carcinoma in patients with Child-Pugh class B and their impact on survival: A Korean nationwide registry study.
Jeon D; Song GW; Lee HC; Shim JH
Liver Int; 2022 Dec; 42(12):2830-2842. PubMed ID: 36287103
[TBL] [Abstract][Full Text] [Related]
13. Vascular Invasion and Metastasis is Predictive of Outcome in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
Mokdad AA; Singal AG; Marrero JA; Zhu H; Yopp AC
J Natl Compr Canc Netw; 2017 Feb; 15(2):197-204. PubMed ID: 28188189
[No Abstract] [Full Text] [Related]
14. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.
Jung YK; Jung CH; Seo YS; Kim JH; Kim TH; Yoo YJ; Kang SH; Yim SY; Suh SJ; An H; Yim HJ; Yeon JE; Byun KS; Um SH
J Gastroenterol Hepatol; 2016 Feb; 31(2):467-74. PubMed ID: 26332049
[TBL] [Abstract][Full Text] [Related]
15. Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread.
Sinn DH; Cho JY; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
PLoS One; 2015; 10(4):e0124434. PubMed ID: 25923439
[TBL] [Abstract][Full Text] [Related]
16. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
17. Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database.
Lee S; Kim BK; Song K; Park JY; Ahn SH; Kim SU; Han KH; Kim DY;
J Gastroenterol Hepatol; 2016 Apr; 31(4):842-7. PubMed ID: 26513311
[TBL] [Abstract][Full Text] [Related]
18. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Sangro B; Carpanese L; Cianni R; Golfieri R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Van Buskirk M; Bilbao JI; Ettorre GM; Salvatori R; Giampalma E; Geatti O; Wilhelm K; Hoffmann RT; Izzo F; Iñarrairaegui M; Maini CL; Urigo C; Cappelli A; Vit A; Ahmadzadehfar H; Jakobs TF; Lastoria S;
Hepatology; 2011 Sep; 54(3):868-78. PubMed ID: 21618574
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis.
Chen YS; Hsieh PM; Lin HY; Hung CM; Lo GH; Hsu YC; Lu IC; Lee CY; Wu TC; Yeh JH; Hsiao P; Li YC; Wang YC; Hsieh KC; Lin CW
BMC Gastroenterol; 2021 May; 21(1):220. PubMed ID: 33990184
[TBL] [Abstract][Full Text] [Related]
20. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.
Cabibbo G; Maida M; Genco C; Parisi P; Peralta M; Antonucci M; Brancatelli G; Cammà C; Craxì A; Di Marco V
World J Hepatol; 2012 Sep; 4(9):256-61. PubMed ID: 23060970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
